D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 55 Citations 18,146 117 World Ranking 2294 National Ranking 1112

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Leukemia

His primary areas of study are Pathology, Immunology, Bone marrow, Leukemia and Myeloid. His Pathology study typically links adjacent topics like Monoclonal antibody. His Immunology research integrates issues from Andrology, Retinoic acid and Family medicine.

His Bone marrow research is classified as research in Internal medicine. Richard D. Brunning does research in Leukemia, focusing on Acute leukemia specifically. Richard D. Brunning has researched Myeloid in several fields, including In vivo, Cytochemistry and Basophilic.

His most cited work include:

  • The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (3594 citations)
  • The World Health Organization (WHO) classification of the myeloid neoplasms. (1819 citations)
  • Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. (912 citations)

What are the main themes of his work throughout his whole career to date?

Richard D. Brunning mostly deals with Pathology, Bone marrow, Leukemia, Immunology and Internal medicine. His research is interdisciplinary, bridging the disciplines of Lymphocyte and Pathology. The various areas that he examines in his Bone marrow study include Chemotherapy, Trephine, Molecular biology, Biopsy and Cytology.

The Leukemia study combines topics in areas such as Myeloid and Myeloid leukemia. While working in this field, Richard D. Brunning studies both Immunology and Cytogenetics. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology, Surgery and Oncology.

He most often published in these fields:

  • Pathology (55.26%)
  • Bone marrow (37.50%)
  • Leukemia (37.50%)

What were the highlights of his more recent work (between 1998-2020)?

  • Pathology (55.26%)
  • Leukemia (37.50%)
  • Myelodysplastic syndromes (5.26%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Pathology, Leukemia, Myelodysplastic syndromes, Myeloid and Internal medicine. His Pathology study incorporates themes from Phagocytosis and Peripheral blood. His studies deal with areas such as Myeloid leukemia and Lymphoma as well as Leukemia.

His Myeloid study improves the overall literature in Immunology. His Internal medicine research incorporates themes from Gastroenterology, Hypogammaglobulinemia, Oncology and LIGHT CHAIN DISEASE. His Acute leukemia research is multidisciplinary, incorporating perspectives in Myeloproliferative neoplasm, Preleukemia, Acute erythroid leukemia and Intensive care medicine.

Between 1998 and 2020, his most popular works were:

  • The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (3594 citations)
  • The World Health Organization (WHO) classification of the myeloid neoplasms. (1819 citations)
  • Diagnostic criteria and classification of mastocytosis: a consensus proposal (853 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Leukemia

Richard D. Brunning spends much of his time researching Pathology, Immunology, Bone marrow, Myelodysplastic syndromes and Internal medicine. His research on Pathology often connects related areas such as Anticorps monoclonal. His Acute erythroid leukemia, Preleukemia and Myelodysplastic–myeloproliferative diseases study in the realm of Immunology interacts with subjects such as De novo Myelodysplastic Syndrome.

His Bone marrow research is multidisciplinary, relying on both Follicular phase, Hair follicle, Biopsy and Follicular lymphoma, Lymphoma. His work deals with themes such as Myeloblast and Granulocyte Precursor Cells, which intersect with Myelodysplastic syndromes. His work in the fields of Internal medicine, such as Hematology, Monoblast and Chronic myelomonocytic leukemia, overlaps with other areas such as Context and Promonocyte.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

James W. Vardiman;Jüergen Thiele;Daniel A. Arber;Richard D. Brunning.
Blood (2009)

5187 Citations

The World Health Organization (WHO) classification of the myeloid neoplasms.

James W. Vardiman;Nancy Lee Harris;Richard D. Brunning.
Blood (2002)

2925 Citations

Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.

Robert J. Risdall;Robert W. McKenna;Mark E. Nesbit;William Krivit.
Cancer (1979)

1420 Citations

Diagnostic criteria and classification of mastocytosis: a consensus proposal

Peter Valent;Hans P. Horny;Luis Escribano;B. Jack Longley.
Leukemia Research (2001)

1176 Citations

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

B D Cheson;P A Cassileth;D R Head;C A Schiffer.
Journal of Clinical Oncology (1990)

962 Citations

Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases.

Sheryl D. Michels;Robert W. McKenna;Diane C. Arthur;Richard D. Brunning.
Blood (1985)

434 Citations

Virus associated hemophagocytic syndrome

Robert W. McKenna;Robert J. Risdall;Richard D. Brunning.
Human Pathology (1981)

365 Citations

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

Ghulam J. Mufti;John M. Bennett;Jean Goasguen;Barbara J. Bain.
Haematologica (2008)

349 Citations

Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia.

Jorge J. Yunis;Michael Lobell;Mark A. Arnesen;Martin M. Oken.
British Journal of Haematology (1988)

326 Citations

Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations

PJ Flynn;WJ Miller;DJ Weisdorf;DC Arthur.
Blood (1983)

322 Citations

Best Scientists Citing Richard D. Brunning

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 240

Ayalew Tefferi

Ayalew Tefferi

Mayo Clinic

Publications: 181

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 133

Animesh Pardanani

Animesh Pardanani

Mayo Clinic

Publications: 122

Pierre Fenaux

Pierre Fenaux

Université Paris Cité

Publications: 98

Guillermo Garcia-Manero

Guillermo Garcia-Manero

The University of Texas MD Anderson Cancer Center

Publications: 97

Mikkael A. Sekeres

Mikkael A. Sekeres

Cleveland Clinic

Publications: 96

Mario Cazzola

Mario Cazzola

University of Pavia

Publications: 90

Clara D. Bloomfield

Clara D. Bloomfield

The Ohio State University

Publications: 89

Olivier Hermine

Olivier Hermine

Université Paris Cité

Publications: 88

Alessandro M. Vannucchi

Alessandro M. Vannucchi

University of Florence

Publications: 87

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 85

Cem Akin

Cem Akin

University of Michigan–Ann Arbor

Publications: 83

Srdan Verstovsek

Srdan Verstovsek

The University of Texas MD Anderson Cancer Center

Publications: 77

Alan F. List

Alan F. List

Precision BioSciences

Publications: 74

Alberto Orfao

Alberto Orfao

University of Salamanca

Publications: 72

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.